Blueprint Medicines
BPMC
#2454
Rank
S$7.94 B
Marketcap
$125.08
Share price
-4.87%
Change (1 day)
7.17%
Change (1 year)

Blueprint Medicines (BPMC) - Cash on Hand

Cash on Hand as of September 2024 : S$1.00 Billion

According to Blueprint Medicines 's latest financial reports the company has S$1.00 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Blueprint Medicines - Cash on Hand chart (from 2014 to 2024)

201620192022$0.5B$1B$1.5B$2Bcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.93 B-25.92%
2022-12-31S$1.26 B96.41%
2021-12-31S$0.64 B-44.08%
2020-12-31S$1.15 B76.92%
2019-12-31S$0.65 B-3.4%
2018-12-31S$0.67 B-25.06%
2017-12-31S$0.90 B190.57%
2016-12-31S$0.30 B34.67%
2015-12-31S$0.23 B268.72%
2014-12-31S$62.42 M2379.46%
2013-12-31S$2.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$59.63 M-94.04%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.55 B-44.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.64 B-35.83%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA